U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. MMT Cattle Incorporated - 02/19/2015
  1. Warning Letters


MMT Cattle Incorporated

Animal & Veterinary

MMT Cattle Incorporated

United States

Issuing Office:
New York District Office

United States


Department of Health and Human Services logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
New York District
158-15 Liberty Avenue
Jamaica, NY 11433  


February 19, 2015
Mr. Marc Tommell, President/Co-Owner
Ms. Nicole L. Tommell, Vice President/Co-Owner
MMT Cattle, Inc.
1942 Hickory Hill Road
Fonda, New York 12068-5930
Dear Mr. and Ms. Tommell:
On October 8 and 15, 2014, the U.S. Food and Drug Administration (FDA) conducted an investigation of your cattle operation located at 1942 Hickory Hill Road, Fonda, New York 12068-5930. This letter notifies you of the violations of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) that we found during our investigation of your operation. You can find the FD&C Act and its associated regulations on the Internet through links on FDA’s web page at www.fda.gov.
We found that you offered for sale an animal for slaughter as food that was adulterated. Under section 402(a)(2)(C)(ii) of the FD&C Act, 21 U.S.C. 342(a)(2)(C)(ii), a food is deemed to be adulterated if it bears or contains a new animal drug that is unsafe under section 512 of the FD&C Act, 21 U.S.C. 360b. Further, under section 402(a)(4) of the FD&C Act, 21 U.S.C. 342(a)(4), a food is deemed to be adulterated if it has been held under insanitary conditions whereby it may have been rendered injurious to health.
Specifically, our investigation revealed that on or about June 3, 2014, you sold a bob veal calf identified with two ear tags, one as (b)(4) and one metal ear tag #(b)(4) for slaughter as food. On or about June 4, 2014, (b)(4), slaughtered this animal. USDA/FSIS analysis of tissue samples collected from this animal detected the presence of lincomycin residue in the kidney tissue. FDA has not established a tolerance for lincomycin in the kidney tissue of cattle as codified in Title 21, Code of Federal Regulations (C.F.R.), Section 556.360 (21 C.F.R. 556.360). The presence of this drug in edible tissue from this animal in this amount causes the food to be adulterated within the meaning of section 402(a)(2)(C)(ii) of the FD&C Act, 21 U.S.C. 342(a)(2)(C)(ii).
Our investigation also found that you hold animals under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply. For example, you failed to maintain complete treatment records, you failed to identify animals transported and delivered for sale at an auction yard, and you held expired drugs in your inventory. Food from animals held under such conditions is adulterated within the meaning of section 402(a)(4) of the FD&C Act, 21 U.S.C. 342(a)(4).
The above is not intended to be an all-inclusive list of violations. As a producer of animals offered for use as food, you are responsible for ensuring that your overall operation and the food you distribute is in compliance with the law.
You should take prompt action to correct the violations described in this letter and to establish procedures to ensure that these violations do not recur. Failure to do so may result in regulatory action without further notice such as seizure and/or injunction. 
You should notify this office in writing of the steps you have taken to bring your firm into compliance with the law within fifteen (15) working days of receiving this letter. Your response should include each step that has been taken or will be taken to correct the violations and prevent their recurrence. If corrective action cannot be completed within fifteen (15) working days of receiving this letter, state the reason for the delay and the time frame within which the corrections will be completed. Please include copies of any available documentation demonstrating that corrections have been made.
Your written response should be sent to LCDR Kristen C. Jackson, Compliance Officer, U.S. Food and Drug Administration, 158-15 Liberty Ave, Jamaica, New York 11433. If you have any questions about this letter, please contact LCDR Jackson at (718) 662-5711, or by e-mail at kristen.jackson@fda.hhs.gov.
Sincerely yours,
Ronald M. Pace         
District Director
New York District
Back to Top